How do I interpret my genomic profiling results for Pancreatic Cancer

Understanding Your Pancreatic Cancer Genomic Profiling Results

I'm glad you're taking an active role in understanding your tumor's molecular profile. This is an important step in personalized cancer treatment. Let me walk you through how to interpret these results.

WHAT GENOMIC PROFILING MEANS

Genomic profiling is a test that examines the DNA of your cancer cells to identify specific mutations (changes in genes), fusions (where pieces of genes join together), and other alterations. Think of it like reading the instruction manual of your cancer cells to find their vulnerabilities.

According to the NCCN Guidelines for Pancreatic Cancer, molecular profiling is now recommended for patients with locally advanced or metastatic disease who are candidates for treatment. This testing helps identify "clinically actionable" alterations—meaning changes that doctors can actually target with specific drugs.

KEY THINGS YOUR REPORT SHOULD SHOW

Your genomic profiling report typically includes:

1. KRAS Mutations (found in ~87% of pancreatic cancers)

• KRAS is the most common driver mutation in pancreatic cancer
• Common variants include G12D, G12V, and G12R
• According to Dr. [removed] O'Reilly's expert guidance, KRAS mutations are "essentially ubiquitous" in pancreatic cancer and represent a critical target
• What it means: Your cancer has this common growth driver; newer KRAS-targeted drugs are now available

2. DNA Repair Gene Mutations (BRCA1, BRCA2, PALB2)

• These genes normally help fix damaged DNA
• If mutated, your cancer cells can't repair themselves properly
• What it means: You may be eligible for PARP inhibitors (drugs like olaparib/Lynparza or rucaparib/Rubraca) and platinum-based chemotherapy, which work particularly well for these mutations

3. Mismatch Repair Deficiency (dMMR) or Microsatellite Instability (MSI)

• These indicate your cancer cells have trouble copying DNA accurately
• What it means: You may be eligible for immunotherapy drugs like pembrolizumab (Keytruda) or dostarlimab (Jemperli)

4. Other Actionable Alterations (less common but important):

• NTRK fusions: Treatable with entrectinib (Rozlytrek) or larotrectinib (Vitrakvi)
• RET fusions: Treatable with selpercatinib (Retevmo)
• BRAF V600 mutations: Treatable with dabrafenib (Tafinlar) + trametinib (Mekinist)
• HER2 amplifications: Being studied for treatment options

HOW TO READ YOUR ACTUAL REPORT

Step 1: Look for the "Interpretation" or "Summary" Section

• This should explain what each finding means in plain language
• It may use terms like "pathogenic," "likely pathogenic," or "variant of uncertain significance"

Step 2: Identify "Actionable" vs. "Non-Actionable" Findings

• Actionable = there's a drug or treatment strategy available
• Non-actionable = important for understanding your cancer but no targeted therapy yet

Step 3: Check the Testing Method

• Next-generation sequencing (NGS): Deep DNA analysis, preferred method
• Immunohistochemistry (IHC): Looks at protein expression
• Both are valid; NGS is more comprehensive

IMPORTANT CONTEXT: GERMLINE vs. SOMATIC TESTING

Your report may include two types of results:

Germline mutations = inherited from your parents (in your normal cells)

• Important for your family members' cancer risk
• May affect treatment eligibility
• According to NCCN Guidelines, genetic testing is now recommended for ALL pancreatic cancer patients

Somatic mutations = acquired during your lifetime (only in cancer cells)

• Directly guides treatment decisions
• Not inherited; won't affect your children's cancer risk

WHAT TO DO WITH YOUR RESULTS

According to Dr. [removed] Strickler's guidance on precision medicine for pancreatic cancer:

1. Get a Copy of the Full Report

• Ask your oncologist: "Can I have a printed copy of my molecular profiling report?"
• Keep this with you—it often lives outside your main medical chart
• Bring it to second opinions and specialist consultations

2. Ask Your Doctor These Specific Questions:

• "Which of these mutations can be targeted with available drugs?"
• "Am I eligible for any clinical trials based on these results?"
• "How do these results change my treatment plan compared to standard chemotherapy?"
• "Should my family members get genetic testing based on any inherited mutations found?"
• "Are there any emerging treatments for my specific mutations?"

3. Consider a Second Opinion

• Academic cancer centers often have molecular tumor boards that review these results
• They can identify clinical trials matching your specific mutations

4. Explore Clinical Trial Options

• Platforms like Massive Bio and myTomorrows (free services) review your [ID removed] and match you to relevant trials
• Cancer Commons offers free second opinions
• PanCAN (Pancreatic Cancer Action Network) has resources and trial matching

WHAT THESE RESULTS DON'T TELL YOU

• Prognosis: Having certain mutations doesn't determine your outcome
• Which drug will work best: Your doctor must consider your overall health, other treatments, and individual factors
• Guaranteed response: Even with actionable mutations, not all patients respond to targeted drugs

REAL-WORLD EXAMPLE

If your report shows:

• ✓ KRAS G12C mutation → You may be eligible for KRAS inhibitors
• ✓ BRCA2 mutation → You may benefit from PARP inhibitors + platinum chemotherapy
• ✓ MSI-high → You may be eligible for immunotherapy

Each of these opens different treatment pathways your oncologist can discuss with you.

NEXT STEPS

1. Request the full report from your oncology team
2. Schedule time to review it with your oncologist (not just a quick phone call)
3. Bring a support person to help you understand and remember the discussion
4. Ask for educational materials explaining your specific findings
5. Consider genetic counseling if germline mutations are found

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

The interpretation of your specific results requires your oncologist's expertise, as they understand your complete clinical picture—your stage, overall health, previous treatments, and individual circumstances. Your doctor will determine which findings are most relevant to your treatment plan.